BioSpace News Archive

Bench International, a leading global executive search firm, announces the addition of industry veteran, Linda Sierra, to serve as Senior Vice President, Business Development.

Paradigm4 unveiled its scalable solution for efficiently working with the Allotrope Data Format (ADF) at the Allotrope Foundation’s Spring Connect meeting (19-26th April 2021).

Adaptive Biotechnologies Corporation a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced it will be participating in the upcoming BofA Securities 2021 Virtual Healthcare Conference.

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, will participate in a virtual fireside chat at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021.

- New analyses of Phase 3 ARTEMIS studies provide further insights on duration and biodegradation of DURYSTA™ (bimatoprost intracameral implant) - Company will share details of patient-reported outcomes from Phase 3 GEMINI trials for AGN-190584 (pilocarpine 1.25%), a proprietary investigational presbyopia treatment

Infinity to Present at the 7 th Annual Truist Securities Life Sciences Summit

Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”), a clinical-stage biopharmaceutical company focused on developing oral therapies enabling the therapeutic use of low dose carbon monoxide (CO), today announced that the company has received a Study May Proceed Letter from the U.S. Food and Drug Administration (FDA) permitting the company to begin its Phase 1 trial for HBI-002,

Lubrizol Life Science – Beauty is partnering with Canadian firm Advonex International Corp. to develop renewable ingredients for the beauty and personal care market.

Berkshire Biomedical, LLC (“Berkshire” or “the Company”), a privately-held digital health company developing a revolutionary virtual care prescription drug delivery and management system only for the Intended User, today announced the appointment of John E. Timberlake as President and Chief Executive Officer.

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the first quarter of 2021, on Tuesday, May 4, 2021, before the U.S. financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss its first quarter 2021 financial results and provide a business update.